Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Estrogens, Conjugated Synthetic A Patent Expiration

Estrogens, Conjugated Synthetic A is used for various conditions ranging from pain management to inflammation. It was first introduced by Aspen Pharma Usa Inc in its drug Cenestin on Mar 24, 1999. Another drug containing Estrogens, Conjugated Synthetic A is Synthetic Conjugated Estrogens A. 2 different companies have introduced drugs containing Estrogens, Conjugated Synthetic A.


Estrogens, Conjugated Synthetic A Patents

Given below is the list of patents protecting Estrogens, Conjugated Synthetic A, along with the drug name that holds that patent and the company name owning that drug.

Filter patents by

Country : United States (US)
Patent Category : All
Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Cenestin US5908638 Pharmaceutical compositions of conjugated estrogens and methods for their use Jul 26, 2015

(Expired)

 Aspen



Estrogens, Conjugated Synthetic A's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Estrogens, Conjugated Synthetic A Generic API Manufacturers

Given below is the list of companies who have filed for Estrogens, Conjugated Synthetic A generic, along with the locations of their manufacturing plants worldwide.